News Archives - Page 83 of 1183 - BioHealth Innovation

News

June 27, 2023

Emergent BioSolutions Announces CEO Transition

GAITHERSBURG, Md., June 27, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS, “Emergent” or the “Company”) today announced that Robert G. Kramer Sr. has informed…

Andy

Love0

News

June 26, 2023

Celebrating Dr. Kurt Newman’s Remarkable Leadership at Children’s National Hospital and in Pediatric Healthcare

As Dr. Kurt Newman, President and CEO of Children’s National Hospital, prepares for retirement, BioHealth Innovation, Inc. (BHI) honors his…

Andy

Love0

News

June 26, 2023

TEDCO Invests SSBCI Funds in Longeviti Neuro Solutions, LLC

Maryland company focused on innovating solutions for complex brain surgeries COLUMBIA, Md. (June 26, 2023) – Jesse Christopher, Longeviti co-founder…

Andy

Love0

News

June 26, 2023

Linshom Medical Launches Clinical Study at Ohio State University Wexner Medical Center

ANNAPOLIS, MARYLAND, UNITED STATES, June 20, 2023/EINPresswire.com/ -- The study, “Advanced Prediction of Respiratory Depression Episodes with Linshom Continuous Predictive…

Andy

Love0

News

June 25, 2023

Unveiling the Life Sciences Landscape: Insights from CBRE Experts on BioTalk with Rich Bendis

Are you curious to discover how experts navigate the complex landscape of life sciences real estate? Want to stay…

Andy

Love0

News

June 23, 2023

Cartesian Therapeutics Announces Landmark Study in The Lancet Neurology of First Successful Clinical Trial of RNA Cell Therapy in Autoimmunity

Modifying patients’ T-cells with mRNA to express a chimeric antigen receptor (rCAR-T therapy), a novel approach to treat myasthenia gravis…

Andy

Love0

News

June 22, 2023

TEDCO Announces Investment into Astek Diagnostics

Maryland life sciences company fighting antibiotic resistance, one innovative tech at a timeCOLUMBIA, Md. (June 22, 2023) – TEDCO, Maryland’s…

Andy

Love0

News

June 21, 2023

Children’s National Hospital Receives $96 Million Investment for Rare Pediatric Brain Tumor Research & Care

The transformational investment is one of the hospital’s largest donations ever. It will power discoveries and revolutionize care for children…

Andy

Love0

News

June 20, 2023

Noble Life Sciences Receives Renewed Accreditation from AAALAC International for Continued Commitment to Ethical Animal Research

Sykesville, Maryland – June 20, 2023Noble Life Sciences, a leading contract research organization in Maryland, is proud to announce that…

Andy

Love0

News

June 20, 2023

Precigen Receives Breakthrough Therapy Designation for PRGN-2012 AdenoVerse™ Immunotherapy for the Treatment of Recurrent Respiratory Papillomatosis

GERMANTOWN, Md. , June 20, 2023 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies…

Andy

Love0

News

Emergent BioSolutions Announces CEO Transition

Celebrating Dr. Kurt Newman’s Remarkable Leadership at Children’s National Hospital and in Pediatric Healthcare

TEDCO Invests SSBCI Funds in Longeviti Neuro Solutions, LLC

Linshom Medical Launches Clinical Study at Ohio State University Wexner Medical Center

Unveiling the Life Sciences Landscape: Insights from CBRE Experts on BioTalk with Rich Bendis

Cartesian Therapeutics Announces Landmark Study in The Lancet Neurology of First Successful Clinical Trial of RNA Cell Therapy in Autoimmunity

TEDCO Announces Investment into Astek Diagnostics

Children’s National Hospital Receives $96 Million Investment for Rare Pediatric Brain Tumor Research & Care

Noble Life Sciences Receives Renewed Accreditation from AAALAC International for Continued Commitment to Ethical Animal Research

Precigen Receives Breakthrough Therapy Designation for PRGN-2012 AdenoVerse™ Immunotherapy for the Treatment of Recurrent Respiratory Papillomatosis

About BioHealth Innovation

Contact

Connect

News

About BioHealth Innovation

Contact

Connect

Search